Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Gaming for the Treatment of Attention Deficit Hyperactivity Disorder

NCT05067322 is registered in ClinicalTrials.gov with Spherix Incorporated as lead sponsor.

NCT NCT05067322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Gaming for the Treatment of Attention Deficit Hyperactivity Disorder
Lead sponsor
Spherix Incorporated
Phase
Not applicable
Overall status
Terminated
Start date
January 9, 2017
Completion date
September 23, 2021
Enrollment
2 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder